Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review

Although cannabis’ major psychoactive component, Δ-9-tetrahydrocannabinol (THC), has been linked to both earlier onset and poorer outcomes of psychotic disorders, Cannabidiol (CBD) seems to have different pharmacological mechanisms and potential therapeutic properties. However, no clinical study has...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartoli, Francesco, Riboldi, Ilaria, Bachi, Bianca, Calabrese, Angela, Moretti, Federico, Crocamo, Cristina, Carrà, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005219/
https://www.ncbi.nlm.nih.gov/pubmed/33810033
http://dx.doi.org/10.3390/jcm10061303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005219/
https://www.ncbi.nlm.nih.gov/pubmed/33810033
http://dx.doi.org/10.3390/jcm10061303

Ejemplares similares